Original Research: Bacillus coagulans Significantly Improved Abdominal Pain and Bloating in Patients with IBS

References

• . American Gastroenterology Association. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology. 2002;123(6):2105–2107
   PubMed Web of Science ®Google Scholar
• . Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002;123(6):2108–2131
   PubMed Web of Science ®Google Scholar
• . Andrews EB, Eaton SC, Hollis KA,. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther. 2005;22(10):935–942
   PubMed Web of Science ®Google Scholar
• . Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005;21(11):1365–1375
   PubMed Web of Science ®Google Scholar
• . Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987;92(5 pt 1):1282–1284
   PubMed Web of Science ®Google Scholar
• . Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997;112(6):2120–2137
   PubMed Web of Science ®Google Scholar
• . Spiller RC, Jenkins D, Thornley JP,. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47(6):804–811
   PubMed Web of Science ®Google Scholar
• . Dunlop SP, Jenkins D, Neal KR, Spiller RC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology. 2003;125(6):1651–1659
   PubMed Web of Science ®Google Scholar
• . Cumberland P, Sethi D, Roderick PJ,; IID Study Executive. The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode. Epidemiol Infect. 2003;130(3):453–460
   PubMed Web of Science ®Google Scholar
• . Collins SM. A case for an immunological basis for irritable bowel syndrome. Gastroenterology. 2002;122(7):2078–2080
   PubMed Web of Science ®Google Scholar
• . Chadwick VS, Chen W, Shu D,. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology. 2002;122(7):1778–1783
   PubMed Web of Science ®Google Scholar
• . Si JM, Yu YC, Fan YJ, Chen SJ. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol. 2004;10(12):1802–1805
   PubMed Web of Science ®Google Scholar
• . Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98(2):412–419
   PubMed Web of Science ®Google Scholar
• . O'Leary C, Quigley EM. Small bowel bacterial overgrowth, celiac disease, and IBS: what are the associations? Am J Gastroenterol. 2003;98(4):720–722
   PubMed Web of Science ®Google Scholar
• . Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol. 2004;38( 6 suppl):S104–S106
   PubMed Web of Science ®Google Scholar
• . Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000;130( 2S suppl):396S–402S
   PubMed Web of Science ®Google Scholar
• . Quigley EM. The use of probiotics in functional bowel disease. Gastroenterol Clin North Am. 2005;34(3):533–545
   PubMed Web of Science ®Google Scholar
• . O'Mahony L, McCarthy J, Kelly P,. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128(3): 541–551
   PubMed Web of Science ®Google Scholar
• . Jiang T, Savaiano DA. Modification of colonic fermentation by bifidobacteria and pH in vitro. Impact on lactose metabolism, short-chain fatty acid, and lactate production. Dig Dis Sci. 1997;42(11):2370–2377
   PubMed Web of Science ®Google Scholar
• . Ouwehand AC, Lagström H, Suomalainen T, Salminen S. Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Ann Nutr Metab. 2002;46(3–4):159–162
   PubMed Web of Science ®Google Scholar
• . De Vecchi E, Drago L. Lactobacillus sporogenes or Bacillus coagulans: misidentification or mislabeling? Int J Probiotics Prebiotics. 2006;1:3–10
   Google Scholar
• . Hyronimus B, Le Marrec C, Sassi AH, Deschamps A. Acid and bile tolerance of spore-forming lactic acid bacteria. Int J Food Microbiol. 2000;61(2-3):193–197
   PubMed Web of Science ®Google Scholar
• . McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol. 2008;14(17):2650–2661
   PubMed Web of Science ®Google Scholar
• . Whorwell PJ, Altringer L, Morel J,. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581–1590
   PubMed Web of Science ®Google Scholar
• . Kim HJ, Vazquez Roque MI, Camilleri M,. A randomized controlled trial of a probiotic combination VSL#3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005;17(5):687–696
   PubMed Web of Science ®Google Scholar
• . Patel SM, Stason WB, Legedza A,. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil. 2005;17(3):332–340
   PubMed Web of Science ®Google Scholar
• . Astegiano M, Pellicano R, Terzi E, Simondi D, Rizzetto M. Treatment of irritable bowel syndrome. A case-control experience. Minerva Gastroenterol Dietol. 2006;52(4):359–363
   PubMedGoogle Scholar
• . Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr. 2001;73( 2 suppl):393S–398S
   PubMed Web of Science ®Google Scholar
• . Marco ML, Pavan S, Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol. 2006;17(2):204–210
   PubMed Web of Science ®Google Scholar
• . Casula G, Cutting SM. Bacillus probiotics: spore germination in the gastrointestinal tract. Appl Environ Microbiol. 2002;68(5):2344–2352
   PubMed Web of Science ®Google Scholar
• . Ara K, Meguro S, Hase T,. Effect of spore-bearing lactic acid-forming bacteria (Bacillus coagulans SANK 70258) administration on the intestinal environment, defecation frequency, fecal characteristics and dermal characteristics in humans and rats. Microb Ecol Health Dis. 2002;14:4–13
   Google Scholar
• . Hyronimus B, Le Marrec C, Urdaci MC. Coagulin, a bacteriocin-like inhibitory substance produced by Bacillus coagulans I4. J Appl Microbiol. 1998;85(1):42–50
   PubMed Web of Science ®Google Scholar